Neutralization of foot-and-mouth disease virus can occur through at least three distinct antigenic sites, involving specific residues on the VP1 protein.
No takes yet. Share an insight, caveat, or question.
Multiple VP1 sites may guide FMDV vaccine design; leaves open validation in livestock challenge models.
Xie et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: